Aluminium clofibrate

A lipid used in proteomics research.

A lipid used in proteomics research.

rMOA-LecBeads [for Galα(1-3)Gal].

The 3rd generation Buchwald palladium catalyst contains blocky RockPhos ligands. The system has been shown to be effective in cross coupling reaction reactions like arylated fatty alcohols.

The 3rd generation Buchwald palladium catalyst contains blocky RockPhos ligands. The system has been shown to be effective in cross coupling reaction reactions like arylated fatty alcohols.

The 3rd generation Buchwald palladium catalyst contains blocky RockPhos ligands. The system has been shown to be effective in cross coupling reaction reactions like arylated fatty alcohols.

SB431542 is a potent and selective inhibitor of ALK5 with IC50 of 94 nM in a cell-free assay, 100-fold more selective for ALK5 than p38 MAPK and other kinases.A specific and selective inhibitor of TGF-β type I ALK receptors and Smad3.

SB431542 is a potent and selective inhibitor of ALK5 with IC50 of 94 nM in a cell-free assay, 100-fold more selective for ALK5 than p38 MAPK and other kinases.A specific and selective inhibitor of TGF-β type I ALK receptors and Smad3.

SB431542 is a potent and selective inhibitor of ALK5 with IC50 of 94 nM in a cell-free assay, 100-fold more selective for ALK5 than p38 MAPK and other kinases.A specific and selective inhibitor of TGF-β type I ALK receptors and Smad3.

SB525334 is a potent and selective inhibitor of TGFβ receptor I (ALK5) with IC50 of 14.3 nM, is 4-fold less potent to ALK4 than ALK5 and inactive to ALK2, 3, and 6.A potent ATP-competitive inhibitor against receptor TbR-I/ALK5.

SB525334 is a potent and selective inhibitor of TGFβ receptor I (ALK5) with IC50 of 14.3 nM, is 4-fold less potent to ALK4 than ALK5 and inactive to ALK2, 3, and 6.A potent ATP-competitive inhibitor against receptor TbR-I/ALK5.

SB525334 is a potent and selective inhibitor of TGFβ receptor I (ALK5) with IC50 of 14.3 nM, is 4-fold less potent to ALK4 than ALK5 and inactive to ALK2, 3, and 6.A potent ATP-competitive inhibitor against receptor TbR-I/ALK5.